Skip to content
777 Sourcing.

From the company

AmideBio discovers peptide therapeutics for metabolic disease, using in-silico design and its proprietary BioPure process to generate ultrapure peptides. Founded in 2009 to commercialize the BioPure platform, it sells peptides directly and offers custom synthesis services, and since 2016 has developed its own therapeutics targeting metabolic diseases, aiming to license drug candidates at or before the IND stage.

Location: LOUISVILLE, CO, USFounded: 2009Capabilities: 5Facilities: 1

Products & services offered

Facilities

Headquarters

331 S 104TH ST, LOUISVILLE, CO 80027, US

View map

Send your requirements

Quantities, certifications, and timing.

Send your requirements · Supplier responds with a quote · Compare and decide

Similar products and services